Gemcitabine and Dipyrone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemcitabine (gemcitabine) and Dipyrone (metamizole). Common drug interactions include pleural effusion among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Gemcitabine and Dipyrone. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

What is Dipyrone?

Dipyrone has active ingredients of metamizole. eHealthMe is studying from 1,876 Dipyrone users. Check the latest studies of Dipyrone.

On Jul, 18, 2026

27 people who take Gemcitabine and Dipyrone together, and have interactions are studied.

Gemcitabine and Dipyrone drug interactions.

What are the common drug interactions of Gemcitabine and Dipyrone, by gender? *:

female:

Pleural effusion (water on the lungs)
Overdose
Vasculitis (inflammation of a blood vessel or blood vessels)
Gastric ulcer (stomach ulcer)
Glomerulonephropathy (any noninflammatory disease of the renal glomeruli)
Intussusception
Pyrexia (fever)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Lung disorder (lung disease)

male:

Blood creatinine increased
C-reactive protein increased
Pleural effusion (water on the lungs)
Pneumonia
Respiratory syncytial virus infection (viral disease of respiratory system)
Septic shock (shock due to blood infection)
Vomiting
Weight increased
Acute myocardial infarction (acute heart attack)
Blood culture positive

What are the common drug interactions of Gemcitabine and Dipyrone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Colitis (inflammation of colon)

40-49:

Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Metastases to brain (cancer spreads to brain)

50-59:

Gastric ulcer (stomach ulcer)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Vomiting
Acute myocardial infarction (acute heart attack)
Arthralgia (joint pain)
Diarrhoea
Dizziness
Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Myalgia (muscle pain)

60+:

Pleural effusion (water on the lungs)
Overdose
Blood creatinine increased
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dysphagia (a condition in which swallowing is difficult or painful)
Gram stain positive
Ileus (a painful obstruction of the ileum or other part of the intestine)
Lung disorder (lung disease)
Neoplasm malignant (cancer tumour)

What are the existing conditions these people have? *

Pancreatic Carcinoma (pancreatic cancer): 5 people, 18.52%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 14.81%
Pain: 4 people, 14.81%
Indigestion: 4 people, 14.81%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 3 people, 11.11%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 11.11%
Tumor Pain: 2 people, 7.41%
High Blood Pressure: 2 people, 7.41%
Abdominal Pain: 2 people, 7.41%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine and Dipyrone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously